ELI LILLY PROPOSES SETTLEMENT OF ITS TESTOSTERONE LITIGATION AFTER ITS MADE UP ILLNESS OF “LOW-T” Eli Lilly, the manufacturer of Axiron Gel, is working on a master settlement plan to end its litigation for claims against it due to the increased risk of heart attack, stroke, blood clots and sudden death.   Axiron was approved to … Continued

At the last Case Management Conference, Judge Fallon expressed a desire to put an end to the litigation caused by Xarelto’s increased risk of increased death due to gastrointestinal bleeds as well as strokes and cranial bleeds and encouraged the parties to start settlement negotiations.  Often when that happens, the practical deadlines to file claims … Continued